Hamidi Amir Abbas, Taghehchian Negin, Zangouei Amir Sadra, Akhlaghipour Iman, Maharati Amirhosein, Basirat Zahra, Moghbeli Meysam
Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Cancer Cell Int. 2023 Feb 5;23(1):19. doi: 10.1186/s12935-023-02865-2.
MicroRNAs (miRNAs) as the members of non-coding RNAs family are involved in post-transcriptional regulation by translational inhibiting or mRNA degradation. They have a critical role in regulation of cell proliferation and migration. MiRNAs aberrations have been reported in various cancers. Considering the importance of these factors in regulation of cellular processes and their high stability in body fluids, these factors can be suggested as suitable non-invasive markers for the cancer diagnosis. MiR-216a deregulation has been frequently reported in different cancers. Therefore, in the present review we discussed the molecular mechanisms of the miR-216a during tumor progression. It has been reported that miR-216a mainly functioned as a tumor suppressor through the regulation of signaling pathways and transcription factors. This review paves the way to suggest the miR-216a as a probable therapeutic and diagnostic target in cancer patients.
微小RNA(miRNA)作为非编码RNA家族的成员,通过抑制翻译或降解信使核糖核酸(mRNA)参与转录后调控。它们在细胞增殖和迁移的调节中起关键作用。在各种癌症中均有微小RNA异常的报道。鉴于这些因子在细胞过程调控中的重要性及其在体液中的高稳定性,这些因子可被视为癌症诊断的合适非侵入性标志物。在不同癌症中,经常有miR-216a失调的报道。因此,在本综述中,我们讨论了miR-216a在肿瘤进展过程中的分子机制。据报道,miR-216a主要通过调节信号通路和转录因子发挥肿瘤抑制作用。本综述为将miR-216a作为癌症患者可能的治疗和诊断靶点铺平了道路。